Peter Bisgaard is a Managing Director and Managing General Partner at Pivotal Life Sciences / Pivotal bioVenture Partners, where he invests at seed, early stage, Series B/C, growth, late stage, and in public markets across life sciences (biotechnology, drug development, therapeutics, medical devices, diagnostics, healthcare innovation, and pharmaceuticals). He is operating a $389 million fund raised in December 2023 and invests in companies across the United States, Europe, and China. He serves on the boards of Eargo, Nevro, Otonomy, Entasis, and Bolt Therapeutics, and has invested in companies like RA Pharma, Alder, HTG, InoZyne, and Minerva. Before Pivotal, he was a Senior Partner at Novo and a Consultant at McKinsey & Company. Peter studied at DTU – Technical University of Denmark and lives in the San Francisco Bay Area.
Peter Bisgaard, Managing Director @ Pivotal Life Sciences. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Peter Bisgaard from Pivotal Life Sciences. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Peter
Map your path to Peter instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Peter
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.